CYCC - Cyclacel Pharmaceuticals

-

$undefined

N/A

(N/A)

Cyclacel Pharmaceuticals NasdaqCM:CYCC Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Location: Level 10, Kuala Lumpur, 592000, Malaysia | Website: https://www.cyclacel.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

566.7M

Cash

3.45M

Avg Qtr Burn

-2.689M

Short % of Float

0.30%

Insider Ownership

61.49%

Institutional Own.

6.64%

Qtr Updated

03/31/25